Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Antiphospholipid Syndrome
•
Systemic lupus erythematosus
•
Benign Hematology
•
Anticoagulation
•
Hospital Medicine
How would you approach a patient with SLE and catastrophic antiphospholipid antibody system that has not responded to heparin, steroids, and PLEX?
How do you decide amongst other therapies such as eculizumab, rituximab, cyclophosphamide, IVIg?
Related Questions
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
What is the appropriate interval to obtain a hydroxychloroquine level after making a dosage adjustment?
What factors drive you to prioritize treatments that inhibit T cells vs B cell depletion when choosing therapies for patients with refractory SLE?
What are some practical tips for tacrolimus management/monitoring in SLE nephritis?
Is there any role for IVIG or steroids in viral myositis complicated by severe rhabdomyolysis, diffuse compartment syndrome, DIC, and AKI?
What is typical presentation and time course for belimumab infusion-related depression and/or hallucinations, and how do you approach management?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
How do you explain a very high positive ds-DNA antibody by Elisa but negative by IFA?